Expertise in
4
conditions

Dr. Douglas T. Johnston

Allergy and Immunology
8045 Providence Rd, Suite 300, 
Charlotte, NC 
Accepting New Patients
Offers Telehealth
Expertise in
4
conditions
8045 Providence Rd, Suite 300, 
Charlotte, NC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Douglas Johnston is an Allergy and Immunologist in Charlotte, North Carolina. Dr. Johnston is highly rated in 4 conditions, according to our data. His top areas of expertise are Hereditary Angioedema, Angioedema, Hives, Eosinophilic Esophagitis, and Hormone Replacement Therapy (HRT). Dr. Johnston is currently accepting new patients.

His clinical research consists of co-authoring 31 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Allergy and Immunology
Licenses
Allergy & Immunology in NC
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Absolute Total Care South Carolina
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 3 Less Insurance Carriers -

Locations

8045 Providence Rd, Suite 300, Charlotte, NC 28277

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Multicenter, Open-label Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
A Phase 3, Multicenter, Open-label Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
Enrollment Status: Terminated
Publish Date: February 19, 2025
Intervention Type: Drug
Study Drug: Budesonide oral suspension
Study Phase: Phase 3
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
Expanded Access Program: Lanadelumab for the Prevention of Acute Attacks of Hereditary Angioedema (HAE) in Pediatric Patients 2 to <12 Years of Age and Lanadelumab for the Prevention Against Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)
Expanded Access Program: Lanadelumab for the Prevention of Acute Attacks of Hereditary Angioedema (HAE) in Pediatric Patients 2 to <12 Years of Age and Lanadelumab for the Prevention Against Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)
Enrollment Status: No_longer_available
Publish Date: July 24, 2023
Intervention Type: Drug
An Observational, Non-interventional, Study of Patients With Hereditary Angioedema in the United States and Canada (EMPOWER Study)
An Observational, Non-interventional, Study of Patients With Hereditary Angioedema in the United States and Canada (EMPOWER Study)
Enrollment Status: Completed
Publish Date: March 30, 2023
SPRING STUDY: An Open-Label, Multicenter, Phase 3 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Lanadelumab for Prevention Against Acute Attacks of Hereditary Angioedema (HAE) in Pediatric Subjects 2 to <12 Years of Age
SPRING STUDY: An Open-Label, Multicenter, Phase 3 Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Lanadelumab for Prevention Against Acute Attacks of Hereditary Angioedema (HAE) in Pediatric Subjects 2 to <12 Years of Age
Enrollment Status: Completed
Publish Date: May 26, 2022
Intervention Type: Drug
Study Drug: Lanadelumab
Study Phase: Phase 3
View 5 Less Clinical Trials

31 Total Publications

Oral berotralstat for hereditary angioedema prophylaxis in patients aged 2 to <12 years: APeX-P interim results.
Oral berotralstat for hereditary angioedema prophylaxis in patients aged 2 to <12 years: APeX-P interim results.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: June 03, 2025
Similar Doctors
Expertise in
10
conditions
Dr. Richard Silton
Allergy and Immunology
Expertise in
10
conditions
Dr. Richard Silton
Allergy and Immunology

Carolina Asthma & Allergy Center

2600 E 7th St Unit A, 
Charlotte, NC 
 (8.5 miles away)
833-922-8800
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Richard Silton is an Allergy and Immunologist in Charlotte, North Carolina. Dr. Silton has been practicing medicine for over 44 years is highly rated in 10 conditions, according to our data. His top areas of expertise are Tick Paralysis, Grass Allergy, Allergic Rhinitis, and Sinusitis.

Expertise in
20
conditions
Dr. John Norris
Allergy and Immunology
Expertise in
20
conditions
Dr. John Norris
Allergy and Immunology

Carolina Asthma & Allergy Center

2600 E 7th St Unit A, 
Charlotte, NC 
 (8.5 miles away)
833-922-8800
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Norris is an Allergy and Immunologist in Charlotte, North Carolina. Dr. Norris is highly rated in 20 conditions, according to our data. His top areas of expertise are Grass Allergy, Allergic Rhinitis, Tick Paralysis, and Sinusitis.

Expertise in
17
conditions
Dr. Michael Lapuente
Allergy and Immunology
Expertise in
17
conditions
Dr. Michael Lapuente
Allergy and Immunology

Office

2600 E 7th St Unit A, 
Charlotte, NC 
 (8.5 miles away)
704-372-7900
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Michael Lapuente is an Allergy and Immunologist in Charlotte, North Carolina. Dr. Lapuente is highly rated in 17 conditions, according to our data. His top areas of expertise are Tick Paralysis, Hives, Allergic Rhinitis, and Sinusitis.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Johnston's expertise for a condition
ConditionClose
View All 9 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile